• Login
    • Join
  • FOLLOW:
  • Subscribe Free
    • Magazine
    • eNewsletter
    Checkout
    • Magazine
    • News
    • Opinions
    • Top 30
    • Research
    • Supply Chain
    • Device Sectors
    • Directory
    • Events
    • Resources
    • Microsites
    • More
  • Magazine
  • News
  • Opinions
  • Top 30
  • Research
  • Supply Chain
  • Device Sectors
  • Directory
  • Events
  • Resources
  • Microsites
  • Current / Back Issues
    Features
    Editorial
    Digital Edition
    eNewsletter Archive
    Our Team
    Editorial Guidelines
    Reprints
    Subscribe Now
    Advertise Now
    Top Features
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    OEM News
    Supplier News
    Service / Press Releases
    Online Exclusives
    Press Releases
    People in the News
    Product & Service Releases
    Supplier News
    Medtech Makers
    Technical Features
    International News
    Videos
    Product & Service Releases
    Live From Shows
    Regulatory
    Financial/Business
    Top News
    MCRA Expands Biocompatibility Division With Board-Certified Toxicologist Hire

    ISO 13485 Certification Awarded to Inspira Technologies

    ZOLL Expands Temperature Management Portfolio to Include IQool System

    Steven Goetz Joins Motif Neurotech as Chief Technology Officer

    ZAP Surgical Wins Two More IP Battles with Elekta
    From the Editor
    Blogs
    Guest Opinions
    Top Opinions
    MPO's 2023 Medtech Supply Chain Survey

    Exceeding Medical Device Extrusion Expectations

    Medical Device Micromolders Discuss the 'Minor Details'

    Superior Subtractive Solutions for Machining Medtech

    Assembly & Automation Experts Share Thoughts on Medtech Trends
    Top 30 Medical Device Companies
    Market Data
    White Papers
    Top Research
    Back to School for Medical Device Cybersecurity Training

    Driving Clinical Trial Excellence to Help Study Teams Run a Faster Relay Race

    Medtech’s Supply Chain: From Disruption to Opportunity

    Are Medtech’s Mega-Deals Gone For Good?

    Will a Skilling Gap Hinder Organizational Readiness for Medtech’s New Age of AI?
    3D/Additive Manufacturing
    Contract Manufacturing
    Electronics
    Machining & Laser Processing
    Materials
    Molding
    Packaging & Sterilization
    R&D & Design
    Software & IT
    Testing
    Tubing & Extrusion
    Cardiovascular
    Diagnostics
    Digital Health
    Neurological
    Patient Monitoring
    Surgical
    Orthopedics
    All Companies
    Categories
    Company Capabilities
    Add New Company
    Outsourcing Directory
    Halkey-Roberts Corporation

    Cirtec Medical

    Medbio LLC

    Johari Digital Healthcare Ltd.

    JBC Technologies
    MPO Summit
    Industry Events
    Webinars
    Live From Show Event
    Industry Associations
    Videos
    Career Central
    eBook
    Slideshows
    Top Resources
    How Wearables Are Changing the Way We Collect Real-World Data in Clinical Trials

    Could Medtech Ever Stop a Hospital Killer in Their Tracks?

    A One-Stop-Shop, Turnkey Solution Is Paramount for Success

    How Additive and Subtractive Manufacturing Are Revolutionizing the Medical Device Industry

    Medical Device Commercialization: It’s What, Not When, to Transfer to Manufacturing
    Companies
    News Releases
    Product Releases
    Press Releases
    Product Spec Sheets
    Service Releases
    Case Studies
    White Papers
    Brochures
    Videos
    Outsourcing Directory
    Halkey-Roberts Corporation

    Cirtec Medical

    Medbio LLC

    Johari Digital Healthcare Ltd.

    JBC Technologies
    • Magazine
      • Current/Back Issues
      • Features
      • Editorial
      • Columns
      • Digital Editions
      • Subscribe Now
      • Advertise Now
    • News
    • Directory
      • All Companies
      • ALL CATEGORIES
      • Industry Associations
      • Company Capabilities
      • Add Your Company
    • Supply Chain
      • 3D/Additive Manufacturing
      • Contract Manufacturing
      • Electronics
      • Machining & Laser Processing
      • Materials
      • Molding
      • Packaging & Sterilization
      • R&D & Design
      • Software & IT
      • Testing
      • Tubing & Extrusion
    • Device Sectors
      • Cardiovascular
      • Diagnostics
      • Digital Health
      • Neurological
      • Patient Monitoring
      • Surgical
      • Orthopedics
    • Top 30 Company Report
    • Expert Insights
    • Slideshows
    • Videos
    • eBook
    • Resources
    • Podcasts
    • Infographics
    • Whitepapers
    • Research
      • White Papers
      • Case Studies
      • Product Spec Sheets
      • Market Data
    • MPO Summit
    • Events
      • Industry Events
      • Live From Show Events
      • Webinars
    • Microsite
      • Companies
      • Product Releases
      • Product Spec Sheets
      • Services
      • White Papers / Tech Papers
      • Press Releases
      • Videos
      • Literature / Brochures
      • Case Studies
    • About Us
      • About Us
      • Contact Us
      • Advertise with Us
      • eNewsletter Archive
      • Privacy Policy
      • Terms of Use
    Breaking News

    FDA OKs Abbott's HeartMate 3 for Advanced Heart Failure Patients Ineligible for a Transplant

    The HeartMate 3 heart pump is backed by the industry's strongest long-term data.

    FDA OKs Abbott
    In developing the HeartMate 3 system, Abbott set a new standard in LVAD therapy, reducing the system's size while reimagining how blood passes through a heart pump. Image courtesy of Abbott.
    Abbott Laboratories10.19.18
    Abbott (NYSE: ABT) announced today that the HeartMate 3 Left Ventricular Assist Device (LVAD) has received U.S. Food and Drug Administration (FDA) approval as a destination therapy for people living with advanced heart failure. With the approval, physicians can now offer the HeartMate 3 system to patients not eligible for a transplant who will live with their device for the rest of their lives.
     
    More than 5.7 million Americans suffer from heart failure, and there are approximately 915,000 new patients diagnosed with the disease annually. For advanced heart failure patients who can no longer rely on earlier stage treatment options, LVAD's take the workload off a weakened heart by pumping blood through the body—providing crucial, life-saving support for patients awaiting a heart transplant or for those not able to receive one.
     
    "Approximately a quarter of a million people are living with advanced heart failure, and many of these people will need a heart transplant; however, only a few thousand will receive a new heart," said Nir Uriel, M.D., director of Heart Failure, Transplant and Mechanical Circulatory Support at the University of Chicago Medicine. "The destination therapy approval for Abbott's HeartMate 3 device now gives these patients new hope that they can receive a heart pump clinically proven to mitigate challenges we've historically confronted with this therapy—stroke and blood clotting—while also offering survival rates on par with a transplant."
     
    In developing the HeartMate 3 system, Abbott set a new standard in LVAD therapy, reducing the system's size while reimagining how blood passes through a heart pump. The HeartMate 3 pump utilizes technology known as Full MagLev (fully magnetically-levitated) Flow, which reduces trauma to the blood passing through the pump while improving flow.
     
    "We partner with physicians to holistically develop therapies that benefit patients and achieve better outcomes," said Mike Pederson, senior vice president of Abbott's Cardiac Arrhythmias and Heart Failure business. "The unique design of the HeartMate 3 LVAD—with its Full MagLev Technology—takes an established innovation and improves upon it in meaningful ways to help people with advanced heart failure live fuller lives."
     
    The HeartMate 3 system's U.S. approval was supported by clinical data from the MOMENTUM 3 trial. During the study, patients with the HeartMate 3 LVAD had an unprecedented survival rate of 82.8 percent at two years. Furthermore, rates of suspected pump thrombosis (clotting of blood) remained very low at 1.1 percent at two years. The study also showcased the lowest-ever published stroke rate (10 percent) for a continuous-flow LVAD at two years.
     
    The MOMENTUM 3 study included more than 1,000 patients with New York Heart Association (NYHA) Class IIIB or IV heart failure. Patients were followed for a short-term endpoint of six months and a long-term endpoint of two years. Two-year data on the first 366 patients enrolled into the study were presented at the American College of Cardiology's (ACC) 67th Annual Scientific Session in March 2018 and simultaneously published in the New England Journal of Medicine.
     
    The HeartMate 3 system includes the LVAD pump as well as other components that help power and monitor the technology including an external, wearable controller and battery system. The HeartMate 3 system received CE Mark in Europe for both short-term and long-term support in October 2015 and U.S. FDA approval for short-term support in August 2017.
    Related Searches
    • standard
    • president
    • ce mark
    • fda
    Related Knowledge Center
    • Surgical
    • Cardiovascular
    Suggested For You
    FDA Approves Abbott FDA Approves Abbott's Portico with FlexNav TAVR System
    Indago Announces $10 Million Financing Close and Name Change Indago Announces $10 Million Financing Close and Name Change
    FDA Approves TransMedics FDA Approves TransMedics' OCS Heart System for Donor Hearts
    CorWave Completes Preclinical Study on its Cardiac Pump CorWave Completes Preclinical Study on its Cardiac Pump
    CVRx Completes First Procedure With Ultrasound-Guided Implant Approach CVRx Completes First Procedure With Ultrasound-Guided Implant Approach
    FDA Approves ZOLL FDA Approves ZOLL's remedē for Central Sleep Apnea
    LifeSignals Inc. Receives FDA Approval for Remote Monitoring Platform LifeSignals Inc. Receives FDA Approval for Remote Monitoring Platform
    BioFourmis BioFourmis' Digital Heart Failure Therapeutic Earns Breakthrough Status
    Nevro Corp Receives FDA Approval for Senza System Nevro Corp Receives FDA Approval for Senza System
    CARMAT Celebrates First Aeson Artificial Heart Commercial Implant CARMAT Celebrates First Aeson Artificial Heart Commercial Implant
    Study Confirms Benefits of ZOLL Study Confirms Benefits of ZOLL's Implantable Sleep Apnea Device
    VistaMed, OneProjects and Tyndall Receive €5.1 million to Improve Treatment of Cardiac Arrhythmias VistaMed, OneProjects and Tyndall Receive €5.1 million to Improve Treatment of Cardiac Arrhythmias
    Survey: Patient Focus Breeds Success for Remote Cardiac Monitoring Programs Survey: Patient Focus Breeds Success for Remote Cardiac Monitoring Programs
    FineHeart Successfully Implants, Removes Cardiac Device in Trial FineHeart Successfully Implants, Removes Cardiac Device in Trial
    Receiving FDA Approval in Under One Month Receiving FDA Approval in Under One Month

    Related Breaking News

    • Cardiovascular
      FDA Approves Abbott

      FDA Approves Abbott's Portico with FlexNav TAVR System

      Self-expanding TAVR valve features intra-annular (within the native valve) leaflets.
      PR Newswire 09.20.21

    • Indago Announces $10 Million Financing Close and Name Change

      Indago Announces $10 Million Financing Close and Name Change

      Lazurite Holdings is developing technology to create the operating room of the future.
      Business Wire 09.15.21

    • Cardiovascular
      FDA Approves TransMedics

      FDA Approves TransMedics' OCS Heart System for Donor Hearts

      Indicated for preservation of DBD (donors after brain death) hearts.
      PR Newswire 09.07.21


    • Cardiovascular
      CorWave Completes Preclinical Study on its Cardiac Pump

      CorWave Completes Preclinical Study on its Cardiac Pump

      Data confirmed the ability of the CorWave pump to provide chronic circulatory support with exceptional hemocompatibility.
      Business Wire 08.27.21

    • Cardiovascular
      CVRx Completes First Procedure With Ultrasound-Guided Implant Approach

      CVRx Completes First Procedure With Ultrasound-Guided Implant Approach

      The new approach is the latest advancement in Barostim for treating heart failure symptoms.
      Globe Newswire 08.26.21

    Loading, Please Wait..

    Trending
    • Cardiosense Begins SEISMIC-HF I Heart Failure Trial
    • Danaher Names New Environmental And Applied Solutions Company Veralto
    • Exo Introduces The Exo Iris To Market
    • A New Approach To Post-Market Surveillance
    • Varian Buys Aspekt Solutions To Bolster Advanced Oncology Biz
    Breaking News
    • MCRA Expands Biocompatibility Division With Board-Certified Toxicologist Hire
    • ISO 13485 Certification Awarded to Inspira Technologies
    • ZOLL Expands Temperature Management Portfolio to Include IQool System
    • Steven Goetz Joins Motif Neurotech as Chief Technology Officer
    • ZAP Surgical Wins Two More IP Battles with Elekta
    View Breaking News >
    CURRENT ISSUE

    October 2023

    • MPO's 2023 Medtech Supply Chain Survey
    • Exceeding Medical Device Extrusion Expectations
    • Medical Device Micromolders Discuss the 'Minor Details'
    • View More >

    Cookies help us to provide you with an excellent service. By using our website, you declare yourself in agreement with our use of cookies.
    You can obtain detailed information about the use of cookies on our website by clicking on "More information”.

    • About Us
    • Privacy Policy
    • Terms And Conditions
    • Contact Us

    follow us

    Subscribe
    Nutraceuticals World

    Latest Breaking News From Nutraceuticals World

    PLT Health Solutions Granted Claims for Botanical Ingredient in Canada
    CRN Files Petition with FTC For Clarity on Health Products Compliance Guidance
    Vitafoods Europe Relocates to Barcelona Starting 2025
    Coatings World

    Latest Breaking News From Coatings World

    Hugh Grant to Retire from PPG Board of Directors
    BASF Recognizes Hard Work with Five Prestigious Awards at SEMA
    Arkema Will Decarbonize Acrylics Production at its Carling, France Site
    Medical Product Outsourcing

    Latest Breaking News From Medical Product Outsourcing

    MCRA Expands Biocompatibility Division With Board-Certified Toxicologist Hire
    ISO 13485 Certification Awarded to Inspira Technologies
    ZOLL Expands Temperature Management Portfolio to Include IQool System
    Contract Pharma

    Latest Breaking News From Contract Pharma

    BioCity, AstraZeneca Partner on Treatment of Advanced HCC
    Sartorius, SPARTA Biodiscovery Partner on Nanoparticle Analysis Platform
    Peptone Expands Leadership Team with Key Executive Hires
    Beauty Packaging

    Latest Breaking News From Beauty Packaging

    The Estée Lauder Companies Establishes Atelier in Paris, France
    Maybelline New York Launches Virtual Campaign in Roblox
    Taramar Unveils Skincare Solution Powered by Kelp
    Happi

    Latest Breaking News From Happi

    Black Girl Ventures Foundation, Rare Beauty Brands and JCPenney Reveal 2023 National Competition Finalists
    Catch Partners with Rare Beauty, Introduces First Mobile App
    Haircolor Company oVertone and Franzia Wines Create Limited Edition Hair Conditioners
    Ink World

    Latest Breaking News From Ink World

    International Coatings Re-Releases Paramount White 7041 Ink
    Arkema Will Decarbonize Acrylics Production at Carling, France Site
    Micro Powders Showcases New Natural, PTFE Alternative Additives at 2023 WCS
    Label & Narrow Web

    Latest Breaking News From Label & Narrow Web

    Spinnaker's Troy manufacturing site earns ISO 9001:2015 certification
    APR publishes expanded Global Design Catalog
    Anjou adds Bobst Digital Master 340
    Nonwovens Industry

    Latest Breaking News From Nonwovens Industry

    Goodnites Bedwetting Underwear Recognized by Good Housekeeping
    Ed Thomas Receives INDA Lifetime Technical Service Award
    ExxonMobil Works with JL Goor to Help Drive Growth in Ireland and U.K. Healthcare Sector
    Orthopedic Design & Technology

    Latest Breaking News From Orthopedic Design & Technology

    FDA Clears 4WEB Medical's New Integrated Cervical Plate
    CTL Amedica Granted ECAT Approval from Defense Logistics Agency
    Intech Acquires Lenkbar LLC
    Printed Electronics Now

    Latest Breaking News From Printed Electronics Now

    Emerson Ventures Invests in First Resonance
    Nearly Six in 10 Warehouse Leaders Plan to Deploy RFID by 2028: Zebra
    Wiliot to Show Enhanced Version of Wiliot Cloud, IoT Pixels, at MWC Las Vegas 2023

    Copyright © 2023 Rodman Media. All rights reserved. Use of this constitutes acceptance of our privacy policy The material on this site may not be reproduced, distributed, transmitted, or otherwise used, except with the prior written permission of Rodman Media.

    AD BLOCKER DETECTED

    Our website is made possible by displaying online advertisements to our visitors.
    Please consider supporting us by disabling your ad blocker.


    FREE SUBSCRIPTION Already a subscriber? Login